TRCT
DXCM icon

Tower Research Capital (TRC)’s DexCom DXCM Stock Holding History

Tower Research Capital (TRC)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,000
Closed -$129K – 5998
2023
Q2 		$129K Buy
+1,000
New +$121K ﹤0.01% 1882

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tower Research Capital (TRC)'s DXCM Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its DexCom (DXCM) stake by 7.1% in Q1 2026, buying an estimated $151K and bringing the position to 32,556 shares worth $2.04M. The position accounts for 0.05% of the portfolio, ranked #334.

Tower Research Capital (TRC) first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $13.5M in Q1 2022. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Tower Research Capital (TRC) held 32,556 shares of DexCom worth $2.04M as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,167 DexCom shares in Q1 2026, an estimated $151K.
  • DexCom made up 0.05% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #334 holding.
  • Tower Research Capital (TRC) first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
  • Tower Research Capital (TRC)'s DexCom position peaked at $13.5M in Q1 2022.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.